Go to content

Publications

510 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:

  1. Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

    The National Health Care Institute has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report ...

    Report | 17-04-2018

  2. Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

    The National Health Care Institute has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and ...

    Report | 29-03-2018

  3. Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

    The National Health Care Institute carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the ...

    Report | 01-03-2018

  4. Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

    The National Health Care Institute  carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment ...

    Report | 07-02-2018

  5. Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

    The National Health Care Institute  issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

    Report | 18-01-2018

  6. Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

    Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

    Report | 04-01-2018

  7. Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris

    The motto of the National Health Care Institute is "Taking care of good health care: no more and no less than necessary". Every ...

    Report | 17-12-2017

  8. Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

    Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

    Report | 07-12-2017

  9. Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

    The National Health Care Institute has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone ...

    Report | 20-10-2017

  10. Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

    Publication | 19-10-2017

Go to